Correction to: REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimens
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsRenal cell carcinoma treatment · Cancer Genomics and Diagnostics · Ferroptosis and cancer prognosis
This is a correction to: Jeffrey Zhong, Albert Jang, Bashar Abuqayas, Arnab Basu, David J Benjamin, Vineel Bhatlapenumarthi, Mehmet Asim Bilen, Dhvani Buch, Mark Chang, Erica Chin, Sourat Darabi, Nagendra Dhanikonda, Pooja Ghatalia, Claud M Grigg, Abby L Grier, Tanya Jindal, Joannah Jung, Deepak Kilari, Hamsa L S Kumar, Suzanna Lee, Brittany Neelands, Chinmayi Pandya, Jeff Pawelek, Jaimee Staggers, Ahmet Yildirim, Yousef Zakharia, Kevin K Zarrabi, Michael Zimmerman, George Sledge, David Spetzler, Andrew Elliott, Rana R McKay, Pedro C Barata, REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimens, The Oncologist, Volume 30, Issue 6, June 2025, oyaf135, https://doi.org/10.1093/oncolo/oyaf135
In the originally published version of this manuscript, a typographical error was present in author Jeff Pawelek’s name.
This has been corrected.